SARS-CoV-2 inactivated vaccine (Vero cells) shows good safety in repeated administration toxicity test of Sprague Dawley ratsSARS-CoV-2 불활화백신(Vero cells), Sprague Dawley 쥐 반복투여 독성시험에서 우수한 안전성 입증Article Published on 2021-06-012022-09-11 Journal: Food and chemical toxicology : an international jo [Category] 비임상, [키워드] administration breath change clinical trial clinical trials COVID-19 dose effective evaluate experimental group Formulation global public health Good High-dose inactivated Inactivated vaccine injected Intramuscular injection Local negative control Neutralizing antibodies neutralizing antibody observé outbreak Practice premise Prevent repeated Research Safe Safety SARS-CoV-2 SARS-CoV-2 vaccine severity Spread stimulate The inactivated vaccine The repeated administration toxicity. the vaccine tissues Toxic reaction Toxicity toxicity test Vaccine vaccine group Vero cells virus [DOI] 10.1016/j.fct.2021.112239 PMC 바로가기 [Article Type] Article
Prime-boost vaccination of mice and rhesus macaques with two novel adenovirus vectored COVID-19 vaccine candidates2개의 새로운 아데노바이러스 매개된 COVID-19 백신 후보로 생쥐와 붉은털 원숭이의 프라임 부스트 백신 접종Research Article Published on 2021-06-012022-09-10 Journal: Emerging Microbes & Infections [Category] SARS, 진단, 치료기술, [키워드] Adenovirus animals anti-RBD anti-S binding antibody candidate CD4 cells changes COVID-19 vaccine COVID-19 vaccines detectable dose-dependent manner elicit evaluated FIVE followed by full-length human adenovirus 49 vector IFN-γ IL-2 immune response immune responses Immunity immunization immunogenicity macaque macaques mice mice and non-human primates nCoV pathologic peptide peptides preparation prime-boost regimen prime-boost vaccination priming pseudovirus neutralizing antibody response rhesus macaque rhesus macaques SARS-CoV-2 spike protein simian adenovirus 23 vector Specific Spike protein T cell T-cell Response the vaccine trials vaccination Vaccine [DOI] 10.1080/22221751.2021.1931466 PMC 바로가기 [Article Type] Research Article
Anti-COVID-19 measurements for hidradenitis suppurativa patients화농성한선염 환자의 항 코로나19 측정Article Published on 2021-06-012022-09-12 Journal: Experimental dermatology [Category] MERS, SARS, 진단, [키워드] affected bowel cohorts of patient Consensus COVID-19 COVID-19 patient disease disease severity European Evidence expected foundation Hidradenitis hidradenitis suppurativa incidence of COVID-19 Inflammatory International Conference knowledge management modify Patient patients reported responsible SARS-CoV2 susceptibility syndrome the vaccine Treatment unlikely Vaccine Vaccines virus [DOI] 10.1111/exd.14339 PMC 바로가기 [Article Type] Article
PPAR agonists as effective adjuvants for COVID-19 vaccines, by modifying immunogenetics: a review of literatureReview Published on 2021-05-312022-10-30 Journal: Journal of Genetic Engineering & Biotechnology [Category] COVID-19, [키워드] Abstract adjuvant agonist anti-apoptotic antibody Antigen boost coronavirus vaccine COVID-19 infection COVID-19 vaccine COVID-19 vaccines debatable Effect effective Factor fatty acid oxidation immune immune system Immunologic memory Immunological memory IMPROVE increasingly Interaction long-lived plasma cell mechanisms memory metabolism pandemic PD-L1 peroxisome persistence PPAR Re-infection receptor secretion Seroconversion stimulated switching T cell T cell memory T memory cells T regulatory cells the vaccine upregulating vaccination Vaccine [DOI] 10.1186/s43141-021-00179-2 PMC 바로가기 [Article Type] Review
Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech)Commentary Published on 2021-05-312022-10-29 Journal: Journal of Pharmaceutical Policy and Practice [Category] COVID-19, [키워드] administration adverse event Analysis aspiration pneumonia association benefit BNT162b2 cardiovascular disease causal link cause coronavirus vaccine death died event FIVE hemorrhage Hemorrhagic ICH incidence incompatible Japan Japanese men men and women mortality data Pfizer-BioNTech raised regulatory authority report reported reveal Statistics stroke the vaccine thrombosis venous women [DOI] 10.1186/s40545-021-00326-7 PMC 바로가기 [Article Type] Commentary
Intention to receive a COVID-19 vaccine: results from a population-based survey in CanadaResearch Published on 2021-05-292022-10-28 Journal: BMC Public Health [Category] COVID-19, SARS, [키워드] 95%CI adjusted benefit Canada Care Cohort Committee Community Complete conducted Coverage COVID-19 COVID-19 vaccine determine Factor female General population greater group immunization individual Intention less multivariable multivariable logistic regression Officer Population Practice Practitioner predict public health receive reported Research Result supplementary material Support the vaccine vaccinate vaccinated against COVID-19 Vaccine Vaccine confidence Vaccine hesitancy [DOI] 10.1186/s12889-021-11098-9 PMC 바로가기 [Article Type] Research
Attitudes of Lebanese adults regarding COVID-19 vaccinationCOVID-19 예방 접종에 대한 레바논 성인의 태도Research Published on 2021-05-272022-09-10 Journal: BMC Public Health [Category] SARS, 치료기술, 치료제, [키워드] 95% CI acceptance adjusted odds ratio association Attitude Awareness conducted confirmed case COVID-19 COVID-19 pandemic COVID-19 vaccination COVID-19 vaccine cross-sectional cross-sectional study death effort Factor female gender females Hesitancy knowledge Lebanon lockdown male Neutral pandemic Participants question raising reached receive receiving refusal Region Result Sample size significantly sociodemographic data the vaccine vaccination Vaccine Vaccine hesitancy [DOI] 10.1186/s12889-021-10902-w PMC 바로가기 [Article Type] Research
Determinants of Willingness for COVID-19 Vaccine: Implications for Enhancing the Proportion of Vaccination Among IndiansPreventive Medicine Published on 2021-05-272022-10-31 Journal: Cureus [Category] COVID-19, [키워드] 95% CI acceptance Asthma Cancer chronic obstructive co-morbidity collected conducted COPD coronavirus disease COVID COVID vaccine COVID-19 COVID-19 infection cross-sectional determinant Diabetes Mellitus effective Enhancing expressed Factor Google Government health authorities Healthcare provider Hesitancy hypertension identify India Infection objective Participants Perceived risk platform pulmonary disease questionnaire receive Result socio-demographic the vaccine unwillingness vaccination Vaccine was used Willingness [DOI] 10.7759/cureus.15271 PMC 바로가기 [Article Type] Preventive Medicine
Ethnic and minority group differences in engagement with COVID-19 vaccination programmes – at Pandemic Pace; when vaccine confidence in mass rollout meets local vaccine hesitancyCommentary Published on 2021-05-272022-10-30 Journal: Israel Journal of Health Policy Research [Category] COVID-19, [키워드] adverse effect affected age assessment Community country COVID-19 COVID-19 vaccine determinant dominant drug effort engage Ethnicity Evidence Government greater group groups identify illnesses implementation improvement indicate inequality lack less Local meet methodology pace Pandemic pace Perspective Public public health public health workforce reproductive Respected stimulate the vaccine Toxicity USA vaccination Vaccine Vaccine confidence Vaccine hesitancy Vaccines Variation with COVID-19 [DOI] 10.1186/s13584-021-00467-9 PMC 바로가기 [Article Type] Commentary
Advocacy, Hesitancy, and Equity: Exploring U.S. Race-Related Discussions of the COVID-19 Vaccine on TwitterArticle Published on 2021-05-262022-10-29 Journal: International Journal of Environmental Research an [Category] COVID-19, SARS, [키워드] Adverse reactions Analysis API application conducted content analysis contributing to COVID-19 COVID-19 vaccines demonstrated Efficacy facilitator Health Hesitancy Immunity interface International Intersection nuance people of color Protective public health messaging random representation social media Support the vaccine Twitter Vaccine Vaccine development Vaccine hesitancy [DOI] 10.3390/ijerph18115693 PMC 바로가기 [Article Type] Article